These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21969015)

  • 1. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.
    Izmirly PM; Saxena A; Kim MY; Wang D; Sahl SK; Llanos C; Friedman D; Buyon JP
    Circulation; 2011 Nov; 124(18):1927-35. PubMed ID: 21969015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system.
    Izmirly PM; Saxena A; Sahl SK; Shah U; Friedman DM; Kim MY; Buyon JP
    Ann Rheum Dis; 2016 Jun; 75(6):1161-5. PubMed ID: 26835701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.
    Llanos C; Friedman DM; Saxena A; Izmirly PM; Tseng CE; Dische R; Abellar RG; Halushka M; Clancy RM; Buyon JP
    Rheumatology (Oxford); 2012 Jun; 51(6):1086-92. PubMed ID: 22308531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block.
    Pike JI; Donofrio MT; Berul CI
    Circulation; 2011 Nov; 124(18):1905-7. PubMed ID: 22042925
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal lupus: bedside to bench and back.
    Buyon JP
    Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.
    Morel N; Lévesque K; Maltret A; Baron G; Hamidou M; Orquevaux P; Piette JC; Barriere F; Le Bidois J; Fermont L; Fain O; Theulin A; Sassolas F; Hauet Q; Guettrot-Imbert G; Georgin-Lavialle S; Deligny C; Hachulla E; Mouthon L; Le Jeunne C; Ravaud P; Le Mercier D; Romefort B; Villain E; Bonnet D; Costedoat-Chalumeau N;
    Int J Cardiol; 2017 Dec; 248():263-269. PubMed ID: 28843719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.
    Reed JH; Clancy RM; Lee KH; Saxena A; Izmirly PM; Buyon JP
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1373-81. PubMed ID: 22511615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant spectrum of cardiac manifestations of neonatal lupus in twins.
    Killen SA; Buyon JP; Friedman DM
    Lupus; 2012 Apr; 21(5):559-62. PubMed ID: 22140143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies.
    Guettrot-Imbert G; Cohen L; Fermont L; Villain E; Francès C; Thiebaugeorges O; Foliguet B; Leroux G; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
    J Rheumatol; 2011 Feb; 38(2):378-86. PubMed ID: 21078712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.
    Izmirly P; Saxena A; Buyon JP
    Curr Opin Rheumatol; 2017 Sep; 29(5):467-472. PubMed ID: 28520682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.
    Eliasson H; Sonesson SE; Sharland G; Granath F; Simpson JM; Carvalho JS; Jicinska H; Tomek V; Dangel J; Zielinsky P; Respondek-Liberska M; Freund MW; Mellander M; Bartrons J; Gardiner HM;
    Circulation; 2011 Nov; 124(18):1919-26. PubMed ID: 21986286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
    Keller SB; Cohen J; Moon-Grady A; Cuneo B; Paul E; Coll AC; Campbell M; Srivastava S
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):148-151. PubMed ID: 36806323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal lupus erythematosus: a transplacentally acquired autoimmune disorder.
    McCauliffe DP
    Semin Dermatol; 1995 Mar; 14(1):47-53. PubMed ID: 7742240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.